Press Release

Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton Pharmaceuticals Inc. (“Acton�) including the proprietary product Aerospan. Aerospan is an inhaler for the treatment of asthma that contains the active substance Flunisolide.

The harmful effects of arsenic now include lung damage

A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water - about 12 times the dose generally considered safe - produced lung damage comparable to decades of smoking tobacco. Smoking, especially by males, made arsenic-related damage even worse...

A human antibody that neutralizes 4 different viruses and has the potential to prevent and treat severe lower respiratory tract infections

A publication in the renowned scientific journal Nature describes a unique human monoclonal antibody (MPE8) discovered by the Swiss Biotech company Humabs BioMed SA in collaboration with the Institute for Research in Biomedicine (IRB) which is affiliated to the Universita della Svizzera Italiana (USI)...